

This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
The center's admissions team will work with you to explore the right payment options based on your needs, ensuring you get the best possible treatment.
Located in Philadelphia, this treatment center supports people facing substance use disorder (SUD), mental health challenges, and co-occurring challenges. Levels of care include inpatient detox, psychiatric stabilization, outpatient therapy, and long-term residential programs. Specialized tracks serve men, women, Spanish-speaking participants, and individuals transitioning from homelessness or the justice system. Their mission emphasizes accessible, community-based healing and long-term recovery.
The approach blends medical expertise with creative and evidence-based therapies. Services include medication-assisted treatment (MAT) with methadone, Suboxone, or Vivitrol, alongside individual counseling, group therapy, and psychiatric care. Participants also engage in art, music, and movement therapy, which encourage self-expression and emotional growth. Staff emphasize cultural sensitivity, trauma recovery, and family reunification, tailoring services to support lasting change and community reintegration.
Residential programs focus on structure and stability, pairing clinical care with daily life support. Participants receive 24-hour nursing, psychiatric oversight, and guidance from addiction counselors. Recovery is enriched through access to leisure activities, social and cultural engagement, and supportive housing after treatment. Programs for both men and women create spaces where accountability, integrity, and connection are fostered, helping individuals build life skills and confidence for sustained wellness.

This center treats substance use disorders and mental health conditions. You'll receive individualized care catered to your unique situation and diagnosis, learn practical skills for recovery, and make new connections in a restorative environment.
The Joint Commission accreditation is a voluntary, objective process that evaluates and accredits healthcare organizations (like treatment centers) based on performance standards designed to improve quality and safety for patients. To be accredited means the treatment center has been found to meet the Commission's standards for quality and safety in patient care.

Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT

Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.

Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.

Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.